Snakebite cases and treatment outcomes in the Afar region, Ethiopia: a retrospective and prospective study approach
Transactions of The Royal Society of Tropical Medicine and Hygiene · 2025
DOI: 10.1093/trstmh/traf043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2025. Verfasst von Abebe M Aga und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine, Diagnostics and Medical Device R&D, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Snake Bites, Antivenins. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Health, Ethiopia, Wellcome Trust.
Abstract (Originalsprache)
Background
Snakebite envenomation remains a public health issue, particularly in rural areas. Quick and accurate case identification, coupled with timely treatment, is essential to prevent fatalities and complications.
Methods
Retrospective and prospective data consisted of 245 snakebite cases admitted to hospitals in the Afar region, Ethiopia, from September 2023 to July 2024 (retrospective), while prospective data were collected from July to October 2024. The analysis focused on case prevalence, time to treatment, service availability, treatment received, length of hospital stays, recovery times and patient outcomes.
Results
Of 245 cases, 66.1% (n=162) were retrospective and 33.9% (n=83) prospective. Most patients were male (71.6%); the largest age group was 15–29 y (59.6%); most patients required hospital stays of 2–3 d (56.7%). In the majority of cases, recovery took 4–7 d (36.23%). The fatality rate was 3.3%; >46.54% of patients received treatment >7 d after snakebite, mainly because of the long distance traveled to reach healthcare facilities with access to antivenom.
Conclusions
It is essential to strengthen community health units by equipping them with trained personnel and sufficient antivenom supplies to ensure prompt care. Implementing public awareness and promoting local antivenom production could reduce treatment costs and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine, Diagnostics and Medical Device R&D, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia.
- Afar Region Health Bureau, P.O. Box 26, Semera, Ethiopia.
ORCID-Profile: Abebe M Aga
Förderung
- Ministry of Health, Ethiopia
- Wellcome Trust
Zitieren
APA
Aga, A. M., Mulugeta, D., Motuma, A., Wakitole, B., Mohammed, K., Woldemariyam, F. T., Ferede, H., Teferi, Z., Tadesse, S., Mohammed, J., Alemu, A., Getachew, D., Muleta, D., & Nigussie, D. (2025). Snakebite cases and treatment outcomes in the Afar region, Ethiopia: a retrospective and prospective study approach. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/traf043
Vancouver
Aga AM, Mulugeta D, Motuma A, Wakitole B, Mohammed K, Woldemariyam FT, et al. Snakebite cases and treatment outcomes in the Afar region, Ethiopia: a retrospective and prospective study approach. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025. doi:10.1093/trstmh/traf043
BibTeX
@article{Aga2025,
author = {Aga, Abebe M and Mulugeta, Demise and Motuma, Abera and Wakitole, Bilise and Mohammed, Kedir and Woldemariyam, Fanos Tadesse and Ferede, Henok and Teferi, Zinash and Tadesse, Shambel and Mohammed, Jemal and Alemu, Anberber and Getachew, Dejene and Muleta, Dassalegn and Nigussie, Dereje},
title = {Snakebite cases and treatment outcomes in the Afar region, Ethiopia: a retrospective and prospective study approach},
journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.1093/trstmh/traf043}
}
EUVIMED